Lynne Wagenknecht to Cognition Disorders
This is a "connection" page, showing publications Lynne Wagenknecht has written about Cognition Disorders.
Connection Strength
0.607
-
Coker LH, Wagenknecht LE. Advanced glycation end products, diabetes, and the brain. Neurology. 2011 Oct 04; 77(14):1326-7.
Score: 0.316
-
Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014 Dec 02; 161(11):785-93.
Score: 0.099
-
Dearborn JL, Knopman D, Sharrett AR, Schneider AL, Jack CR, Coker LH, Alonso A, Selvin E, Mosley TH, Wagenknecht LE, Windham BG, Gottesman RF. The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). Dement Geriatr Cogn Disord. 2014; 38(5-6):337-46.
Score: 0.097
-
Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, Coker LH, Coresh J, Couper DJ, Griswold ME, Heiss G, Knopman DS, Patel MD, Penman AD, Power MC, Selnes OA, Schneider AL, Wagenknecht LE, Windham BG, Wruck LM, Mosley TH. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. Am J Epidemiol. 2014 Apr 15; 179(8):956-66.
Score: 0.094